Delivery Order SPE2DB24D6038-SPE2DB25FELXW

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,178,053 units of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The delivery order has a ceiling value of $3,327.84 and a completion date of October 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets in 90-count bottles, with a ceiling value of $1,004.36. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,119.30 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Valsartan-HCTZ 160-25 mg tablets in 90-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $29,795.15 and is a firm fixed-price delivery order with a completion date of February 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The $6,429.84 firm-fixed-price contract has a completion date of February 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
The federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets, with a ceiling value of $9,807.11 and a completion date of July 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov). The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the U.S. military's medical needs. The contract is a...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $24,044.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of January 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Valsartan-HCTZ 160-25 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $1,983.37 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $9,941.69, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price and an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,614.28, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB24D6038
    Indefinite Delivery Contract
  • SPE2DB24D6038-SPE2DB25FELXW
    Delivery Order

This federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a ceiling value of $1,460.53 and a completion date of March 10, 2025. The contract is for firm-fixed-price delivery and does not have a set-aside designation, indicating open competition.

Generated 6/6/25, 10:04 AM